[{"id":"62adebca-4b95-438d-afa0-1e8661c4fb8b","acronym":"","url":"https://clinicaltrials.gov/study/NCT05262530","created_at":"2022-03-02T16:52:30.929Z","updated_at":"2025-02-25T16:26:48.535Z","phase":"Phase 1/2","brief_title":"Safety and Preliminary Efficacy Trial of BNT142 in Patients with CLDN6-positive Solid Tumors","source_id_and_acronym":"NCT05262530","lead_sponsor":"BioNTech SE","biomarkers":" CLDN6","pipe":" | ","alterations":" CLDN6 positive","tags":["CLDN6"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CLDN6 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e BNT142"],"overall_status":"Recruiting","enrollment":" Enrollment 330","initiation":"Initiation: 03/28/2022","start_date":" 03/28/2022","primary_txt":" Primary completion: 10/01/2025","primary_completion_date":" 10/01/2025","study_txt":" Completion: 04/01/2026","study_completion_date":" 04/01/2026","last_update_posted":"2025-01-31"}]